Building a Medical Logistics Platform through a Strategic Business Partnership with H.U. Group Holdings
First written in FY2021-Q1. 8 of 10 entries say "Advanced", first in FY2022. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「We are steadily working to build one of Japan's largest healthcare logistics platforms supporting medical care, health, and beauty.」
In addition to the direction of starting Medisket's business and undertaking logistics services for external companies, the Company obtained ISO 9001 certification at 9 ALC locations, establishing a specific quality foundation for its healthcare logistics platform. - 2026-05-25AdvancedGeneral Meetings of Shareholders
「In addition, in August 2025, メディスケット Co., Ltd. (Misato, Saitama; hereinafter, “メディスケット”) obtained ISO 9001 certification, the international standard for quality management systems, at 9 affiliated ALC facilities as part of an important initiative to further improve logistics quality to a higher level based on global standards for pharmaceutical logistics.」
メディスケット’s efforts to improve logistics quality advanced to the concrete achievement of ISO 9001 certification at 9 ALC facilities. - FY2025AdvancedAnnual report
「Gross profit increased by ¥5,065 million, or 4.2%, due to higher revenue and the expansion of Medisket Corporation's business, among other factors.」
The expansion of Medisket's business emerged as a factor behind the increase in gross profit, making its contribution to consolidated performance more tangible. - FY2025-H1AdvancedAnnual report
「Gross profit increased by ¥5,065 million, or 4.2%, due to higher revenue and the expansion of Medisket Corporation's business (Misato, Saitama; hereinafter, Medisket), among other factors.」
The expansion of Medisket's business was cited as a factor behind the increase in gross profit, making its contribution to consolidated performance more tangible. - FY2024AdvancedAnnual report
「Medisket, the joint venture between the Company and H.U. Group Holdings Corporation (Minato-ku, Tokyo), will create new revenue opportunities not only by improving efficiency through the consolidation of the two companies' logistics operations, but also by undertaking logistics services for external companies. Medisket aims to build one of Japan's largest healthcare logistics platforms supporting medical care, health, and beauty, and is currently working to establish the foundation for shared logistics.」
The partnership with H.U. Group Holdings progressed from the full-scale launch of Medisket to the creation of revenue opportunities by undertaking logistics services for external companies and establishing a shared logistics platform. - FY2024-Q1AdvancedAnnual report
「Medisket (hereinafter, Medisket) began operations in December 2022, contributing to the increase in revenue for the current fiscal year.」
With respect to Medisket, the logistics joint venture with H.U. Group Holdings, the disclosure stated that its contribution to the increase in revenue in FY2024-Q1 followed the start of operations in December 2022. - FY2023-Q3AdvancedAnnual report
「In April 2022, the Company established Medisket Corporation (Misato, Saitama), a logistics joint venture in the medical and healthcare field, with H.U. Group Holdings Corporation (Minato-ku, Tokyo). The company began operations by region on a phased basis from 1 December of the same year. In addition to optimizing the supply of pharmaceuticals, testing materials, and other products and the collection of specimens for clinical, clinical trial, and research purposes, we will promote the participation of a wide range of healthcare-related companies by leveraging high-quality logistics services compliant with GDP guidelines.」
The partnership with H.U. Group Holdings progressed to the establishment of Medisket in April 2022 and the start of operations by region from 1 December. - FY2022AdvancedAnnual report
「In March 2022, we entered into a joint venture basic agreement with H.U. Group Holdings Corporation (Shinjuku-ku, Tokyo) concerning the establishment of a logistics joint venture in the medical and healthcare field, and in April of the same year established Medisket Corporation (Misato, Saitama; hereinafter, Medisket). Through Medisket, the two companies will optimize the supply of pharmaceuticals, testing materials, and other products and the collection of specimens for clinical, clinical trial, and research purposes, while promoting the participation of a wide range of healthcare-related companies by providing high-quality logistics services compliant with GDP guidelines.」
The partnership with H.U. Group Holdings progressed from a joint venture basic agreement to the establishment of Medisket, creating a specific framework for supplying pharmaceuticals and testing materials, collecting specimens, and providing GDP-compliant logistics. - FY2021RestatedAnnual report
「In June 2020, we entered into an agreement with H.U. Group Holdings Corporation (formerly Miraca Holdings Corporation; Shinjuku-ku, Tokyo) regarding a strategic business partnership.」
The strategic business partnership with H.U. Group Holdings and the concept for a medical logistics platform are continuing. - FY2021-Q1First statedAnnual report
「As part of these initiatives, in June 2020 we entered into an agreement with H.U. Group Holdings Co., Ltd. (formerly Miraca Holdings Co., Ltd.; Shinjuku-ku, Tokyo) regarding a strategic business alliance. We will combine the Group’s pharmaceutical-distribution network and expertise with the company’s logistics capabilities for high-quality clinical testing. We will also examine various opportunities in the regenerative-medicine field, which is expected to grow, and aim to build a medical logistics platform in the medical and healthcare sectors.」
In June 2020, the Company entered into an agreement with H.U. Group Holdings regarding a strategic business partnership and began efforts to build a medical logistics platform integrating the pharmaceutical distribution network and clinical testing logistics functions.